Cequent Pharmaceuticals News
Most Popular Cequent Pharmaceuticals Story
MDRNA forges $46M RNAi merger pact with Cequent
RNAi developer MDRNA has struck a deal to merge with Cequent Pharmaceuticals in a transaction the companies valued at $46 million. MDRNA gets a new cancer program poised to begin Phase I, Cequent's Read more...
Latest Headlines
- April 1, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
